Chiuppesi, Flavia http://orcid.org/0000-0002-2921-5377
Nguyen, Vu H.
Park, Yoonsuh
Contreras, Heidi
Karpinski, Veronica http://orcid.org/0000-0002-4562-0583
Faircloth, Katelyn
Nguyen, Jenny
Kha, Mindy
Johnson, Daisy
Martinez, Joy
Iniguez, Angelina
Zhou, Qiao
Kaltcheva, Teodora
Frankel, Paul
Kar, Swagata
Sharma, Ankur
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Shostak, Yuriy http://orcid.org/0000-0003-2891-7905
Wussow, Felix http://orcid.org/0000-0001-7624-6734
Diamond, Don J. http://orcid.org/0000-0003-3579-7083
Funding for this research was provided by:
Comprehensive Cancer Center, City of Hope (IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV, IDDV)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI128913)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA111412, CA181045, CA107399)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 4 October 2021
Accepted: 15 December 2021
First Online: 21 January 2022
Competing interests
: Funds were allocated to D.J.D. by the City of Hope (COH) for research that resulted in the development of COH04S1, the multi-antigenic SARS-CoV-2 vaccine using a synthetic poxvirus platform that is discussed in this publication. While unknown whether publication of this report will aid in receiving grants and contracts, it is possible that this publication will be of benefit to COH. COH had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript. COH submitted two PCT applications. D.J.D. is a co-inventor on two patent applications that were submitted by COH to the USPTO. One patent application (PCT/US2021/016247) covers the design and construction of the synthetic MVA platform, and another patent application (PCT/US2021/032821) covers the development of a COVID-19 vaccine. F.W. is a co-inventor of the same two PCT applications that apply to D.J.D. F.C. is a co-inventor of the PCT application that covers the development of a COVID-19 vaccine. All remaining authors that have not been referenced above have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the interpretation of the article.